Core Viewpoint - The article emphasizes the importance of identifying companies with deep economic moats for long-term investment success, highlighting that many investors confuse short-term advantages with long-term barriers [2][3]. Group 1: Economic Moats - The article categorizes economic moats into six types: brand premium, network effects, scale cost advantages, high user switching costs, core technology barriers, and resource exclusivity [3]. - Brand value is not just about recognition but also about consumers' willingness to pay a premium [3]. - Network effects create a positive feedback loop where the value of a platform increases with more users [3]. Group 2: Misconceptions about Moats - Common misconceptions that can lead to investment risks include: technology leadership that is easily iterated, reliance on a single blockbuster product, short-term traffic benefits, channel advantages under pressure, and over-dependence on management capabilities [3]. - These factors may provide temporary growth but lack structural barriers, making them less reliable for long-term investment [3]. Group 3: Investment Analysis - In dynamic competitive markets, the strength of an economic moat determines investment certainty [3]. - Instead of chasing superficial high-growth data, it is crucial to analyze whether a company possesses pricing power or user lock-in capabilities [3].

Core Viewpoint - The article discusses the challenges and strategies of asset allocation in the context of the high volatility of the A-share market, emphasizing the need for diversified investment approaches to mitigate systemic risks [1]. Group 1: Asset Allocation Strategies - The article highlights various classic asset allocation models, such as the 60/40 stock-bond portfolio and the all-weather portfolio, which have been historically validated but are limited in domestic application due to investment target restrictions [1]. - The Snowball app offers a "three-part method" for asset allocation, allowing users to conduct risk assessments and receive intelligent recommendations for asset class ratios, which can be manually adjusted [3][9]. Group 2: Performance and Timing Issues - The article notes that while historical returns and maximum drawdowns of asset allocation strategies may appear favorable, actual performance can differ significantly, as evidenced by a tracked portfolio yielding only 5.48% over a year [11]. - It emphasizes that expected returns are positively correlated with asset selection and holding time, while the timing of purchases significantly impacts short-term experiences and returns [12][13]. Group 3: Dynamic Rebalancing - The concept of dynamic rebalancing is introduced as a method to maintain target asset ratios and manage risk actively, rather than merely chasing returns [23]. - Key aspects of dynamic rebalancing include mean reversion during market fluctuations, proactive risk management, and enhancing long-term return stability and holding experience [24][25][26]. - The Snowball platform provides reminders for when and how to rebalance, offering clear guidance and explanations for asset adjustments, thereby improving the investment experience [27].

我们质疑他人的观点，也要考虑时间这个背景因素，比如2015年看好恒大和融创，并没有问题， 在2020年三道红线之前这些公司也是高分红高增速，给投资者带来了很好的回报，也是价值投资 的典范。 再比如在2022年之前，我看新能源供应链的公司，比如多次提到卖铲子的晶盛机电和先导智能等 公司盈利不错，但是在供需关系发生转变之后，这些企业的基本面就完全变了。 风险提示：本文所提到的观点仅代表个人的意见，所涉及标的不作推荐，据此买卖，风险自负。 作者：菜头日记 来源：雪球 上市公司的基本面是动态变化的，我们做投资，需要持续跟踪这个变化。 任何人或者机构表达看好某家公司，都需要把时间这个定语加进去。 但是中国经济还在高速增长，向上的空间是无限大的。 从赔率上来讲，2700点没有任何理由不满仓啊。 从结果上看，完全印证了判断，年末，满载而归。 因此，所谓的好公司，也是有时间限制的。 到了2023年的时候，菜头就多次公开表示对于所有新能源产业链上的供应链公司都应该保持谨 慎，并且也在专栏里面剔除了所有相关的公司。 尤其是专栏里面，大家现在回头去看的话，2020~2022年我提醒最多的就是白酒和医药板块估值 泡沫的风险，2022 ...

Group 1 - The global market experienced a significant downturn, with the Dow Jones index dropping nearly 800 points, marking a 1.79% decline, the largest single-day drop in nearly five weeks [2][5] - The primary trigger for this market turmoil is the sudden escalation of tensions in the Middle East, leading to a surge in safe-haven assets like gold and oil [3][13] - The fear index (VIX) spiked over 15%, indicating a sharp increase in market anxiety [4][5] Group 2 - European markets also faced declines, with France and Germany both dropping slightly over 1%, while the UK saw a smaller decline of 0.39% [5] - Energy stocks benefitted from rising oil prices, with companies like ExxonMobil and Diamondback Energy showing significant gains [6] - Defense stocks gained traction due to geopolitical conflicts, with Lockheed Martin and Raytheon Technologies performing strongly [6] Group 3 - Airline stocks suffered due to high oil prices, with Delta Airlines, United Airlines, and American Airlines experiencing declines between 3% and 5% [8] - Technology stocks showed mixed performance, with Oracle reaching new highs while Adobe fell over 5%, and major tech giants like Apple and Nvidia also underperformed [10] - Chinese concept stocks generally weakened, with the China Golden Dragon Index down 2.74%, and companies like Alibaba and JD.com experiencing slight pullbacks [10][11] Group 4 - The escalation of military conflict between Israel and Iran has been identified as a core event, with Iran launching over 100 drones into Israeli territory [14][15] - Oil prices surged significantly, with WTI crude rising over 7% to around $73 per barrel, marking the largest single-day increase since March 2022 [15] - Gold prices also saw a strong rise, with COMEX gold futures increasing by 1.48% to $3452.60 per ounce, accumulating a 3.17% increase for the week [15][16] Group 5 - The Federal Reserve may delay interest rate cuts due to persistent inflation pressures, exacerbated by rising oil prices [17][18] - If oil prices reach $100 per barrel, gasoline prices in the U.S. could rise significantly, potentially pushing overall inflation rates higher [18] - Market expectations for interest rate cuts have decreased, with projections now indicating approximately 1.9 cuts by the end of 2025, down from previous expectations [18]

Group 1 - The core viewpoint of the article highlights the dual effects of the business development (BD) wave in China's innovative pharmaceutical industry, questioning whether BD is a lifeline or a chronic poison for companies [2][3] - The surge in BD transactions is driven by multiple factors, including the patent cliff crisis faced by multinational pharmaceutical companies and the accumulation of potential first-in-class (FIC) and best-in-class (BIC) pipelines by Chinese firms [2] - The total amount of BD transactions in China's innovative drug sector reached $57.1 billion in 2024, with over $50 billion in transactions occurring from early 2025 to the present [2] Group 2 - The benefits of BD are evident, including rapid cash flow acquisition, leveraging multinational resources for global development, and enhancing international recognition of Chinese innovative drugs [3] - However, there are significant concerns, such as a high return rate of 40% in BD transactions, with 25 out of 62 transactions in 2020 being terminated [3] - Companies that rely heavily on BD, like Kangfang Biotech, may face severe financial challenges if BD revenues decline, as seen with a 95% drop in 2024 [3] Group 3 - Successful companies typically possess differentiated innovation capabilities, such as Kangfang Biotech's PD-1/CTLA-4 bispecific antibody [4] - Internationalization capabilities are crucial, exemplified by BeiGene's successful entry into the U.S. market while maintaining its R&D pace [5] - A reasonable pipeline structure is also important, as demonstrated by Ascentage Pharma's high revenue-sharing ratio of 15% for Olverembatinib, potentially generating $300 million in future revenue [6] Group 4 - Companies that are merely "bare swimming" exhibit characteristics such as product homogeneity and reliance on single BD transactions, which can lead to significant market value loss [6] - The CXO companies, particularly those in contract manufacturing organizations (CMO), are clear beneficiaries of the BD trend, as they provide essential production capabilities for innovative drug projects [7] - WuXi Biologics' "CRDMO+" model allows deep involvement in the entire lifecycle of innovative drugs, ensuring continuous orders and revenue regardless of the success of BD transactions [8] Group 5 - After the BD wave subsides, only companies that can consistently produce high-quality innovative drugs and effectively commercialize them will emerge as true winners [9] - Companies must possess strong R&D capabilities and clear commercialization paths, while those relying solely on BD for funding may struggle when the tide recedes [9] - BD should be viewed as a means rather than an end, with the marathon of innovative drug development just beginning [9]

昨夜全球市场突遭重挫，黑天鹅再度突袭。 美股方面，道琼斯指数重挫近800点，跌幅高达1.79%，创下近五周最大单日跌幅；标普500和纳斯达克分别下跌1.13%和1.30%。 这次突如其来的市场动荡，主要导火索指向中东局势的突然升级。受此影响，黄金与原油等避险资产飙升。 01 全球股市震荡，美股三大指数下挫 恐慌指数飙升逾15% 欧洲开盘已经开始下跌，到深夜收盘时，法国德国的跌幅略超1%，英国的跌幅稍微小一些，但也下跌了0.39%。 美国股市遭遇抛售，截至收盘，道琼斯工业平均指数暴跌近800点，跌幅高达1.79%，创下近五周单日最大跌幅；标普500指数和纳斯达克指数分别下跌 1.13%和1.30%，市场情绪全面恶化。 恐慌指数陡升逾15%至20点上方。 科技股表现分化，Oracle连续上涨并再创新高，而Adobe则大幅下挫超过5%。苹果、英伟达等科技巨头亦表现不佳。 中概股普遍走弱，中国金龙指数下跌了2.74%，阿里巴巴、京东、百度纷纷小幅回调。 | | 中概股 明星股 涨幅榜 跌幅榜 换手率 成交割:三 | | | | --- | --- | --- | --- | | 名称 | 最新价 ◆ | 涨跌幅 ◆ ...

受外围地缘冲突影响，亚太股市普跌，日本、韩国、印度市场均跌近1%，A股三大指数集体调整，截至发稿，沪指、深指、创业板指均跌超 0.6%，全市场超4000只个股下跌。 板块方面，美容、医药、传媒、白酒等跌幅居前，黄金和原油受到以色列和伊朗冲突升级影响大涨。 01 国际原油价格飙涨 原油股拉升 能源股集体爆发，通源石油开盘20%涨停，准油股份一字涨停，潜能恒信等涨停或涨超10%。 消息面，当地时间 12日凌晨，以空军正在对伊朗境内数十个与核计划和其他军事设施相关的目标发动空袭，并且将此次行动命名为"狮子的力 量"。以军称，伊朗拥有足够的浓缩铀，可以在几天内制造出多枚炸弹，因此需要采取行动应对这一"迫在眉睫的威胁"。以色列总理表示，以军对 伊朗核设施的军事行动将持续数日，直至消除威胁为止。 此外，美国进入夏季石油需求旺季，原油库存超预期下降。当地时间 11日美国能源信息署（EIA）发布的最新库存数据显示，截至上周末，美国原 油库存4.32亿桶，减少364万桶；库欣地区原油库存2368.3万桶，减少40万桶。 受诸多因素共同影响，布伦特原油和 WTI原油盘中均飙涨超10%，都创3年多来最大单日涨幅。 中信证券表示，近 ...

港股互联网和科技目前估值比较合理 ， 并有一定的向上增速 ， 但是由于巨头的体量比较大 ， 今年年初也有一波上涨 ， 目前弹性相对差一点 ， 但属于优秀资产 ， 适合长期投资者持有 ， 并大概率有相对不错的回报 。 三 、 创新药 风险提示：本文所提到的观点仅代表个人的意见，所涉及标的不作推荐，据此买卖，风险自负。 作者： 边城浪子1986 来源：雪球 一 、 低利率下的稳定回报行业 低利率的环境下 ， 一部分资金自然会寻找股息较高的行业进行投资 ， 并且这些行业的股息回报 也成为了部分银行存款和理财的替代选择 。 特别是保险类资金在大幅加仓高股息个股 ， 红利策 略也在市场上越来越受欢迎 。 我个人觉得其中的公用事业 、 电信运营商 、 电力是值得低风险 偏好的投资者持有的 。 个人疑虑比较大的是银行业 ， 因为资产的真实质量存疑 ， 但是如果未来通过通胀或者放水等手 段稀释不良资产 ， 只要这一过程持续够久 ， 银行也可以看作是安全 ， 就看时间的力量能不能 化解这一切了 。 二 、 港股互联网与科技 创新药是最近最火的板块之一 ， 而且市值除了个别巨头 ， 普遍较为适中 ， 那么弹性相对较好 。 目前创 ...

风险提示：本文所提到的观点仅代表个人的意见，所涉及标的不作推荐，据此买卖，风险自负。 作者： 边城浪子1986 目前创新药处于不可证伪阶段 ， 业绩不是第一位 ， 事件驱动更为重要 ， 大概率在未来一段时 间可能还有一定表现机会 ， 后期会不会出现鸡犬升天的现象 ？ 个人觉得还是存在一定概率的 ， 就是存在未来大部分创新药从合理估值到高估的过程 。 四 、 Ai应用 来源：雪球 一 、 低利率下的稳定回报行业 低利率的环境下 ， 一部分资金自然会寻找股息较高的行业进行投资 ， 并且这些行业的股息回报 也成为了部分银行存款和理财的替代选择 。 特别是保险类资金在大幅加仓高股息个股 ， 红利策 略也在市场上越来越受欢迎 。 我个人觉得其中的公用事业 、 电信运营商 、 电力是值得低风险 偏好的投资者持有的 。 个人疑虑比较大的是银行业 ， 因为资产的真实质量存疑 ， 但是如果未来通过通胀或者放水等手 段稀释不良资产 ， 只要这一过程持续够久 ， 银行也可以看作是安全 ， 就看时间的力量能不能 化解这一切了 。 二 、 港股互联网与科技 港股互联网和科技目前估值比较合理 ， 并有一定的向上增速 ， 但是由于巨头的体 ...

Core Viewpoint - The article argues that the decline in China's liquor production is often misinterpreted, suggesting that while production has decreased from its peak in 2016, it has actually increased by 33.02% compared to 20 years ago, indicating that the industry is not necessarily in decline but rather adjusting to market realities [2][4]. Production Trends - In 2016, China's liquor production peaked at 1,358 million tons, but by 2024, it is projected to drop to 414.5 million tons, a decline of approximately 69.48% [2]. - When comparing the production in 2024 (414.5 million tons) to 20 years prior in 2004 (311.6 million tons), it shows a growth of 33.02%, contradicting the narrative of a declining industry [2][3]. Demand and Consumption - The article highlights that the demand for liquor is limited by human consumption capacity, unlike other beverages that can see increased consumption with lifestyle changes [3]. - The population growth from 1.299 billion in 2004 to 1.408 billion in 2024 (an increase of about 8.4%) indicates that per capita liquor consumption has not significantly decreased [2]. Market Dynamics - The rapid increase in liquor production from 2004 to 2016 was driven by a favorable economic environment post-WTO accession, leading to a proliferation of local liquor brands [4]. - The oversupply and intense competition in the market have led to a decline in production since 2016, with many mid to low-end brands losing market share [4]. Revenue Growth - Despite the decline in production, the total sales revenue of the liquor industry has surged from 61.23 billion in 2004 to 796.384 billion in 2024, a twelvefold increase [4][5]. - The increase in revenue is attributed to rising prices rather than increased consumption, with the sales revenue continuing to grow even as production declines [5]. Monetary Influence - The growth in liquor sales revenue aligns closely with the increase in the money supply (M2), which rose from 25.32 trillion in 2004 to 313.53 trillion in 2024, an increase of 11.38 times [5]. - The article posits that the driving force behind the liquor industry's growth is not public spending or real estate demand, but rather the effects of monetary expansion [5].